慢性丙型肝炎合并2型糖尿病患者HCV载量与糖代谢指标的相关性分析

doi:10.3969/j.issn.1671-7171.2023.04.004

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (1144 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】 To investigate the correlation between hepatitis C virus (HCV) load and glucose metabolism in patients with chronic hepatitis C (CHC) and type 2 diabetes (T2DM). 【Methods】 From March 2019 to February 2021,98 patients with CHC and T2DM (combined group) and 76 patients with simple CHC (CHC group) admitted to our hospital were selected. In addition,80 healthy volunteers who underwent physical examination in our hospital were selected as the control group,and the clinical data and glucose metabolism indicators of the three groups were compared. The patients with CHC and T2DM were divided into four subgroups according to the different HCV loads:virus negative group,low viral load group,medium viral load group,and high disease load group. The levels of glucose metabolism indicators in CHC and T2DM patients with different HCV loads were compared; Pearson correlation was used to analyze the relationship between HCV load and glucose metabolism indicators in patients with CHC and T2DM. 【Results】 There were significant differences in body mass index (BMI),total cholesterol (TC),and low density lipoprotein cholesterol (LDL-C) levels among the three groups (P<0.05); The levels of BMI,TC,LDL-C in the combined group were higher than those in the CHC group and the control group (P<0.05). The levels of fasting blood glucose (FPG),2-hour postprandial blood glucose (2hPG),glycosylated hemoglobin (HbA1c),and fasting insulin (FINS) in the three groups were significantly different (P<0.05); The levels of FPG,2hPG,HbA1c,and FINS in the combined group were higher than those in the CHC group and the control group (P<0.05). The levels of FPG,2hPG,HbA1c,and FINS in patients with CHC and T2DM with different HCV loads were significantly different (P<0.05); The levels of FPG,2HPG,HbA1c,and FINS in the low viral load group,the medium viral load group,and the high viral load group were higher than those in the virus negative group (P<0.05); The levels of FPG,2hPG,HbA1c,and FINS in the high viral load group were higher than those in the low viral load group and the medium viral load group (P<0.05). In patients with CHC and T2DM,HCV load was not correlated with 2hPG and FINS levels (P>0.05),but was positively correlated with FPG and HbA1c levels (P<0.05). 【Conclusion】 Compared with CHC patients and healthy individuals,glucose metabolism in patients with CHC and T2DM is significantly abnormal,and there is a certain correlation between HCV load and FPG,HbA1c in patients with CHC and T2DM.

Key words： Hepatitis C,Chronic/CO Diabetes Mellitus,Type 2/CO Hepacivirus Glycated Hemoglobin A/AN Blood Glucose/AN

Received: 28 July 2022

PACS:

R512.63

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WANG Min
	TAN Xin-yan
	XU Jiao

Cite this article:

WANG Min,TAN Xin-yan,XU Jiao. Correlation between HCV Load and Glucose Metabolism in Chronic Hepatitis C Patients with Type 2 Diabetes[J]. JOURNAL OF CLINICAL RESEARCH, 2023, 40(4): 492-495.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2023.04.004 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2023/V40/I4/492

[1] 刘冬宇,白劼,张文华,等.丙型肝炎病毒患者抗病毒干预持续应答后发生肝细胞肝癌的临床特征[J].医学临床研究,2021,38(3):356-358.
[2] 欧阳清慧,王冰,杨自力,等. 四川省绵阳地区慢性丙型肝炎患者继发2型糖尿病危险因素分析[J].现代检验医学杂志,2020,35(4):157-159.
[3] 程艳冬,董晨,杨东辉,等. 合并2型糖尿病的乙型肝炎病毒感染者和普通感染者肝细胞损害和病毒学标志比较[J].医学研究杂志,2020,9(3):119-121.
[4] 纪冬,游绍丽,辛绍杰. 《丙型肝炎防治指南(2015年更新版)》要点解读[J].传染病信息,2016,29(1):20-23.
[5] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J].中国实用内科杂志,2018,38(4):34-86.
[6] 霍华德.托马斯. 病毒性肝炎[M]. 3版.天津:天津翻译出版社,2013:38-40.
[7] 罗维,付超,徐倩. 外周血miR-155水平与HCV导致的胰岛素抵抗合并2型糖尿病的相关性分析[J].临床和实验医学杂志,2020,19(4):373-376.
[8] 贾学友,藏小晴.血清miR-122水平对慢性丙型肝炎患者肝纤维化程度的诊断价值[J].医学临床研究,2021,38(3):403-405.
[9] 黄建霞,王宁,李成彪,等. 丙型肝炎病毒RNA载量与丙型肝炎病毒相关性免疫性血小板减少症的相关性分析[J].临床内科杂志,2019,26(10):25-29.
[10] 庞梦圆,华瑞. 促凝血失衡对无脂肪变性的慢性丙型肝炎患者心血管和肝损伤的影响[J].临床肝胆病杂志,2019,35(10):189.
[11] 刘小英,刘云,方向明,等. 慢性丙型肝炎合并2型糖尿病患者血糖水平控制的横断面调查研究[J].中国地方病防治杂志,2019,34(3):292-293.
[12] CHEN Y,JI H Z,SHAO J G,et al. Different hepatitis C virus infection statuses show a significant risk of developing type 2 diabetes mellitus:a network meta-analysis[J].Dig Dis Sci,2020,65(7):1940-1950.
[13] HUSSEIN H A,ALLAM A S,MOATY A. Evaluation of glycated haemoglobin (HbA1c) level in type 2 diabetic chronic HCV non-cirrhotic treatment-naive egyptian patients eradicated with sofosbuvir plus daclatasvir[J].Curr Diabetes Rev,2020,16(2):165-170.
[14] ADINOLFI L E,PETTA S,FRACANZANI A L,et al. Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct-acting antiviral therapy:A prospective study[J].Diabetes Obes Metab,2020,22(12):2408-2416.